4//SEC Filing
Stevenson Sharon 4
Accession 0001214659-19-004755
CIK 0001427570other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:30 PM ET
Size
8.1 KB
Accession
0001214659-19-004755
Insider Transaction Report
Form 4
Stevenson Sharon
Director
Transactions
- Award
Common Stock (Restricted Stock Units)
2019-07-23+78,125→ 105,597 total
Holdings
- 546,233(indirect: By Okapi Ventures, L.P.)
Common Stock
- 341,235(indirect: By Okapi Ventures II, L.P.)
Common Stock
Footnotes (4)
- [F1]This award will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the annual meeting of the Issuer's stockholders immediately following the grant date.
- [F2]Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.
- [F3]These securities are held of record by Okapi Ventures, L.P. ("OV"). Okapi Venture Partners, LLC ("OVLLC") is the general partner of OV. The reporting person is a managing director of OVLLC, and shares voting and investment power over the securities. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner of these securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
- [F4]These securities are held of record by Okapi Ventures II, L.P. ("OVII"). Okapi Venture Partners II, LLC ("OVIILLC") is the general partner of OVII. The reporting person is a managing director of OVIILLC, and shares voting and investment power over the securities. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person is a beneficial owner of these securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001683904
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:30 PM ET
- Size
- 8.1 KB